KRM Ayurveda IPO GMP is currently at ₹20 as of 20 January 2026, based on the latest activity in the grey market. The grey market premium gives an early indication of how the IPO is being perceived by informal market participants before its official listing.
The IPO has an upper price band of ₹135 per share. Based on the current KRM Ayurveda IPO GMP, the estimated listing price is around ₹155 (14.81%) per share. At the current level, the GMP indicate weak sentiment ahead of listing. A positive GMP usually reflects decent investor interest, while a lower GMP signals cautious sentiment.
Highest GMP value of KRM Ayurveda IPO: ₹20 on 17 January 2026
Lowest GMP value of KRM Ayurveda IPO: ₹15 on 15 January 2026
Contents
KRM Ayurveda IPO Day-wise GMP Trend
| Date | IPO Price | GMP | Est. Listing | Gain | Trend |
|---|---|---|---|---|---|
| 20-Jan-2026 | ₹135 | ₹20 | ₹155 | 14.81% | FLAT |
| 19-Jan-2026 | ₹135 | ₹20 | ₹155 | 14.81% | FLAT |
| 18-Jan-2026 | ₹135 | ₹20 | ₹155 | 14.81% | FLAT |
| 17-Jan-2026 | ₹135 | ₹20 | ₹155 | 14.81% | UP |
| 16-Jan-2026 | ₹135 | ₹18 | ₹153 | 13.33% | UP |
| 15-Jan-2026 | ₹135 | ₹15 | ₹150 | 11.11% | UP |
| 14-Jan-2026 | ₹135 | ₹0 | ₹135 | 0% | FLAT |
Disclaimer: IPO GMP, Kostak, and Subject to Sauda (Sub2) rates are unofficial and shared for informational purposes only. We do not trade or recommend participation in the grey market. GMP is not a guarantee of listing performance. Investors should apply after reviewing the company’s fundamentals and official offer documents.
KRM Ayurveda IPO Details
| Particulars | Details |
|---|---|
| IPO Open Date | January 21, 2026 |
| IPO Close Date | January 23, 2026 |
| Face Value | ₹10 per equity share |
| IPO Price Band | ₹128 to ₹135 per share |
| Issue Size | Approx ₹77 Crores |
| Fresh Issue | Approx ₹77 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | View PDF |
| RHP Draft Prospectus | View PDF |
Also Read: KRM Ayurveda IPO
KRM Ayurveda IPO Dates
| Event | Date |
|---|---|
| IPO Open Date | January 21, 2026 |
| IPO Close Date | January 23, 2026 |
| Basis of Allotment | January 27, 2026 |
| Refunds Initiation | January 28, 2026 |
| Credit to Demat Account | January 28, 2026 |
| IPO Listing Date | January 29, 2026 |
| IPO Bidding Cut-off Time | January 23, 2026 – 5 PM |
KRM Ayurveda Lots Details
| Activity | Date |
|---|---|
| Issue Price | ₹128.00-135.00 |
| Market Lot | 1,000 Shares |
| Individual Investor | ₹2,70,000 |
| Min HNI Lots | 3000 shares (3 lots) |
KRM Ayurveda Business & Financial Health
KRM Ayurveda operates in the fast-growing ayurveda and wellness healthcare segment, supported by rising consumer preference for natural and alternative treatments. The company has shown a strong recovery in FY2025, with a significant jump in profitability and improved operating margins.
Expansion of telemedicine services and physical healthcare infrastructure positions the company for scalable growth. However, its debt-to-equity ratio remains moderately high, indicating reliance on borrowings.
Asset growth and improving cash flows provide comfort, but sustained performance will depend on efficient execution and regulatory compliance in healthcare services.
KRM Ayurveda GMP FAQs
What is the latest KRM Ayurveda IPO GMP today?
The current GMP is ₹20 as of 20 January 2026. It reflects the unofficial grey market sentiment ahead of the listing.
What is the estimated listing price of KRM Ayurveda IPO?
Estimated listing price is around ₹155 (14.81%) per share of KRM Ayurveda IPO. Actual listing price may differ.
What is the minimum market lot for KRM Ayurveda SME IPO?
The minimum market lot size is 1,000 shares, requiring an investment of approximately ₹2,70,000 at the issue price.
What is the estimated profit per lot in KRM Ayurveda IPO?
The estimated profit is calculated as:
Market lot size × GMP = Estimated Profit
Expert Review
The ₹20 GMP for KRM Ayurveda IPO reflects improving market interest ahead of listing. While the premium signals positive sentiment, investors should not rely only on GMP. Long-term returns will depend on business execution, margins sustainability, and post-listing liquidity typical to SME stocks.
